{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:01:50Z","timestamp":1793916110924,"version":"4.8.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015226","name":"Shengjing Hospital","doi-asserted-by":"publisher","award":["M1358"],"award-info":[{"award-number":["M1358"]}],"id":[{"id":"10.13039\/501100015226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015226","name":"Shengjing Hospital","doi-asserted-by":"publisher","award":["M1357"],"award-info":[{"award-number":["M1357"]}],"id":[{"id":"10.13039\/501100015226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023JH2\/101700141"],"award-info":[{"award-number":["2023JH2\/101700141"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejrad.2025.112521","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:33:30Z","timestamp":1763660010000},"page":"112521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["mpMRI-based interpretable machine learning model for predicting castration-resistant prostate cancer risk"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4332-6591","authenticated-orcid":false,"given":"Siang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3431-7423","authenticated-orcid":false,"given":"Shen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2025.112521_b0005","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejrad.2025.112521_b0010","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1200\/GO.20.00421","article-title":"Treatment of localized and locally advanced, high-risk prostate cancer: a report from the first prostate cancer consensus conference for developing countries","volume":"7","author":"Khauli","year":"2021","journal-title":"Jco Glob. Oncol."},{"key":"10.1016\/j.ejrad.2025.112521_b0015","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3390\/app10062000","article-title":"Castration-resistant prostate cancer outcome prediction using phased long short-term memory with irregularly sampled serial data","volume":"10","author":"Park","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ejrad.2025.112521_b0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1470-2045(14)71205-7","article-title":"Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study","volume":"16","author":"Ryan","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejrad.2025.112521_b0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer","volume":"79","author":"Cornford","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2025.112521_b0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejca.2021.02.042","article-title":"Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer","volume":"150","author":"Scher","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejrad.2025.112521_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102847","article-title":"Practical utility of liquid biopsies for evaluating genomic alterations in castration-resistant prostate cancer","volume":"15","author":"Jeong","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejrad.2025.112521_b0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.prnil.2016.07.002","article-title":"Prostate cancer biomarkers: are we hitting the mark?","volume":"4","author":"McGrath","year":"2016","journal-title":"Prostate Int."},{"key":"10.1016\/j.ejrad.2025.112521_b0045","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1111\/cas.16267","article-title":"Prostate cancer cancer-associated fibroblasts with stable markers post-androgen deprivation therapy associated with tumor progression and castration resistant prostate cancer","volume":"115","author":"Pan","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejrad.2025.112521_b0050","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.21037\/tau-2025-242","article-title":"Interpretable machine learning driven biomarker identification and validation for prostate cancer","volume":"14","author":"Yuan","year":"2025","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.ejrad.2025.112521_b0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41585-019-0212-4","article-title":"Multiparametric MRI for prostate cancer diagnosis: current status and future directions","volume":"17","author":"Stabile","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ejrad.2025.112521_b0060","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222276","article-title":"Interactive explainable deep learning model informs prostate cancer diagnosis at MRI","volume":"307","author":"Hamm","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112521_b0065","article-title":"Interpretable multiparametric MRI radiomics-based machine learning model for preoperative differentiation between benign and malignant prostate masses: a diagnostic, multicenter study","volume":"15","author":"Zhou","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2025.112521_b0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41747-022-00282-0","article-title":"Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics","volume":"6","author":"Liberini","year":"2022","journal-title":"Eur. Radiol. Exp."},{"key":"10.1016\/j.ejrad.2025.112521_b0075","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1109\/RBME.2017.2739801","article-title":"Advances in Monte Carlo simulation for light propagation in tissue","volume":"10","author":"Periyasamy","year":"2017","journal-title":"IEEE Rev. Biomed. Eng."},{"key":"10.1016\/j.ejrad.2025.112521_b0080","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1038\/s41598-025-90444-y","article-title":"Machine learning-based identification of co-expressed genes in prostate cancer and CRPC and construction of prognostic models","volume":"15","author":"Fan","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejrad.2025.112521_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091556","article-title":"A multiparametric MRI and baseline-clinical-feature-based dense multimodal fusion artificial intelligence (MFAI) model to predict castration-resistant prostate cancer progression","volume":"17","author":"He","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.ejrad.2025.112521_b0090","article-title":"Multimodal data integration for predicting progression risk in castration-resistant prostate cancer using deep learning: a multicenter retrospective study","volume":"14","author":"Zhou","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2025.112521_b0095","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.240078","article-title":"Development and validation of a deep learning model based on MRI and clinical characteristics to predict risk of prostate cancer progression","volume":"7","author":"Roest","year":"2025","journal-title":"Radiol. Imaging Cancer"},{"key":"10.1016\/j.ejrad.2025.112521_b0100","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.2147\/IJGM.S465031","article-title":"Development and validation of a clinic machine learning classifier for the prediction of risk stratifications of prostate cancer bone metastasis progression to castration resistance","volume":"17","author":"Li","year":"2024","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.ejrad.2025.112521_b0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.21147\/j.issn.1000-9604.2022.03.07","article-title":"National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)","volume":"34","author":"Health","year":"2022","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.ejrad.2025.112521_b0110","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1200\/JCO.2017.75.3657","article-title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 CHAARTED Trial","volume":"36","author":"Kyriakopoulos","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112521_b0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.21873\/anticanres.15470","article-title":"The role of fast and deep PSA response in castration-sensitive prostate cancer","volume":"42","author":"Iacovelli","year":"2022","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejrad.2025.112521_b0120","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/1008-682X.174856","article-title":"Serum testosterone level predicts the effective time of androgen deprivation therapy in metastatic prostate cancer patients","volume":"19","author":"Wang","year":"2017","journal-title":"Asian J. Androl."},{"issue":"2","key":"10.1016\/j.ejrad.2025.112521_b0125","first-page":"e11","article-title":"PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: multicenter validation in patients from the Chinese prostate cancer consortium","volume":"38","author":"Pei","year":"2020","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.ejrad.2025.112521_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14184404","article-title":"Characterizing circulating tumor cells and tumor-derived extracellular vesicles in metastatic castration-naive and castration-resistant prostate cancer patients","volume":"14","author":"Isebia","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejrad.2025.112521_b0135","doi-asserted-by":"crossref","first-page":"16159","DOI":"10.1038\/s41598-022-20079-w","article-title":"Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells","volume":"12","author":"Khan","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejrad.2025.112521_b0140","doi-asserted-by":"crossref","first-page":"18016","DOI":"10.1038\/s41598-022-22854-1","article-title":"Efficacy of cabazitaxel and androgen splicing variant-7 status in circulating tumor cells in Asian patients with metastatic castration-resistant prostate cancer","volume":"12","author":"Ashizawa","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejrad.2025.112521_b0145","article-title":"Circulating tumor DNA and tissue complementarily detect genomic alterations in metastatic hormone-sensitive prostate cancer","volume":"27","author":"Yang","year":"2024","journal-title":"Iscience"},{"key":"10.1016\/j.ejrad.2025.112521_b0150","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00432-021-03642-2","article-title":"Biopsy-detected Gleason grade 5 tumor is an additional prognostic factor in metastatic hormone-sensitive prostate cancer","volume":"148","author":"Lim","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112521_b0155","article-title":"Comprehensive analysis of the progression mechanisms of CRPC and its inhibitor discovery based on machine learning algorithms","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejrad.2025.112521_b0160","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1186\/s12967-023-04320-2","article-title":"The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistance","volume":"21","author":"Liu","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejrad.2025.112521_b0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/eus.0000000000000094","article-title":"Deep learning segmentation architectures for automatic detection of pancreatic ductal adenocarcinoma in EUS-guided fine-needle biopsy samples based on whole-slide imaging","volume":"13","author":"Udri\u0219toiu","year":"2024","journal-title":"Endosc. Ultrasound"},{"key":"10.1016\/j.ejrad.2025.112521_b0170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/eus.0000000000000113","article-title":"The role of artificial intelligence and deep learning in determining the histopathological grade of pancreatic neuroendocrine tumors by using EUS images","volume":"14","author":"Kiremitci","year":"2025","journal-title":"Endosc. Ultrasound"},{"key":"10.1016\/j.ejrad.2025.112521_b0175","doi-asserted-by":"crossref","unstructured":"M.J. Baine, Utilization of radiomics in prognostication and treatment response, Artif. Intell. Radiat. Oncol. pp. 273-304.","DOI":"10.1142\/9789811263545_0013"},{"key":"10.1016\/j.ejrad.2025.112521_b0180","doi-asserted-by":"crossref","unstructured":"R. Thukral, A. Arora, A. Kumar, T. Dora, S. Sancheti, Effectiveness of Passive Thermography in Predicting Mucositis in Head and Neck Cancer Patients Using Light-Weight Convolutional Neural Networks Approach, 2025, pp. 1-13.","DOI":"10.1007\/978-981-96-2124-8_1"},{"key":"10.1016\/j.ejrad.2025.112521_b0185","unstructured":"A. Kumar, Advancements in Computer Vision: Bridging Perception and Intelligence 7 (2025) 1."},{"key":"10.1016\/j.ejrad.2025.112521_b0190","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232635","article-title":"Fully automated deep learning model to detect clinically significant prostate cancer at MRI","volume":"312","author":"Cai","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112521_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15184437","article-title":"T2-weighted MRI radiomic features predict prostate cancer presence and eventual biochemical recurrence","volume":"15","author":"Duenweg","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejrad.2025.112521_b0200","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1148\/radiol.210875","article-title":"Local extent of prostate cancer at MRI versus prostatectomy histopathology: associations with long-term oncologic outcomes","volume":"302","author":"Wibmer","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112521_b0205","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.230143","article-title":"Development and validation of a multimodality model based on whole-slide imaging and biparametric MRI for predicting postoperative biochemical recurrence in prostate cancer","volume":"6","author":"Hu","year":"2024","journal-title":"Radiol. Imaging Cancer"},{"key":"10.1016\/j.ejrad.2025.112521_b0210","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/jmri.29386","article-title":"Added value of [18F]PSMA-1007 PET\/CT and PET\/MRI in patients with biochemically recurrent prostate cancer: impact on detection rates and clinical management","volume":"61","author":"Abrahamsen","year":"2025","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.ejrad.2025.112521_b0215","doi-asserted-by":"crossref","first-page":"30822","DOI":"10.1038\/s41598-025-16362-1","article-title":"Artificial intelligence model for predicting early biochemical recurrence of prostate cancer after robotic-assisted radical prostatectomy","volume":"15","author":"Bergero","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejrad.2025.112521_b0220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2967\/jnumed.120.245456","article-title":"PSMA-ligand PET for early castration-resistant prostate cancer: a retrospective single-center study","volume":"62","author":"Weber","year":"2021","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejrad.2025.112521_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174270","article-title":"Development of discordant hypermetabolic prostate cancer lesions in the course of [(177)Lu]PSMA radioligand therapy and their possible influence on patient outcome","volume":"13","author":"Hartrampf","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejrad.2025.112521_b0230","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/s41391-021-00391-8","article-title":"The prognostic power of 18F-FDG PET\/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients","volume":"24","author":"Bauckneht","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25006072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25006072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:20:00Z","timestamp":1778692800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X25006072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":46,"alternative-id":["S0720048X25006072"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112521","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mpMRI-based interpretable machine learning model for predicting castration-resistant prostate cancer risk","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112521"}}